Biogen Idec misses Street sales projections; reports death of patient who took its drug

Sales of a Biogen Idec blockbuster multiple sclerosis drug fell 1.6 percent short of consensus Wall Street projections...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.